Browse the corpus

Asthma is a common chronic respiratory disease that continues to challenge clinicians despite the availability of effective therapies. Characterized by airway inflammation, bronchial hyperreactivity, and mucus overproduction, asthma frequently leads to poor symptom control, recurrent exacerbations, and increased health care utilization. Optimal management requires a thorough understanding of evolving pharmacologic options and adherence to evidence-based guidelines. This activity provides a focused review of asthma medications, including their mechanisms of action, clinical indications, and safety profiles. Learners will explore how these therapies align with current guideline-based recommendations and strategies for individualized treatment selection. The course emphasizes practical approaches to improving medication efficacy, minimizing adverse effects, and addressing common barriers such as improper inhaler technique. Interprofessional collaboration among physicians, nurses, pharmacists, and respiratory therapists is highlighted as essential to optimizing patient outcomes. Participation in this activity enhances clinical competence in delivering patient-centered, evidence-based asthma care. Objectives: Identify the key inflammatory and bronchoconstrictive pathways that drive asthma symptoms and exacerbations. Evaluate the mechanisms of action, clinical indications, and safety profiles of major asthma drug classes to guide evidence-based patient care. Select guideline-recommended asthma medications based on individual patient characteristics and risk factors. Implement effective interprofessional collaboration and communication to optimize treatment outcomes for patients with asthma. Access free multiple choice questions on this topic.

Asthma is a common chronic inflammatory airway disease marked by variable airflow obstruction, bronchial hyperresponsiveness, and airway remodeling. It results from an inappropriate immune response to environmental and nonenvironmental triggers, leading to airway smooth muscle constriction, mucus overproduction, and persistent inflammation. Management emphasizes long-term symptom control and prevention of exacerbations through pharmacologic therapy and patient education. Asthma affects millions of adults and children worldwide and remains a major contributor to health care utilization and missed time at school or work.[1] A range of medication classes is used to manage chronic asthma, aiming to improve symptoms and prevent exacerbations. These include short-acting beta-2 agonists (SABAs), long-acting beta-2 agonists (LABAs), short-acting muscarinic antagonists (SAMAs), long-acting muscarinic antagonists (LAMAs), inhaled and systemic corticosteroids, eicosanoid modifiers, and newer biologics and biosimilars. Effective management emphasizes long-term symptom control and prevention of exacerbations through evidence-based pharmacologic therapy combined with patient education.[2][3][4]

Asthma is a widespread condition affecting individuals across all age groups, and even well-controlled cases can abruptly worsen into severe, life-threatening attacks. Optimal management relies on a collaborative interprofessional approach. Accurate diagnosis involves physicians and advanced practice providers who confirm variable airflow limitation using spirometry and clinical evaluation while ruling out other conditions. Pharmacists optimize inhaled corticosteroid therapy, ensure correct dosing, monitor for drug interactions, and promote proper inhaler technique and adherence. Nurses provide patient education, reinforce written action plans, monitor symptoms, and offer vaccination guidance. Specialists such as pulmonologists and immunologists tailor treatment to asthma phenotypes and escalate therapy to biologics when indicated, particularly in type 2 inflammatory asthma. Pharmacists and respiratory therapists support ongoing symptom monitoring, acute care, and long-term management, with evidence showing that pharmacist-led interventions improve adherence.[45][46] During severe exacerbations, emergency physicians and critical care teams coordinate urgent interventions, including bronchodilation, systemic corticosteroids, oxygen therapy, or ventilation, and ensure safe transition to long-term control medications. Effective communication and collaboration among physicians, advanced practice providers, specialists, pharmacists, nurses, and respiratory therapists are essential for minimizing adverse effects and optimizing patient outcomes in asthma pharmacotherapy. Central to improving outcomes is patient education, including trigger avoidance and adherence to prescribed therapies.